| Title | A simple high-performance liquid chromatographic method for the determination of diclofenac in human plasma: application to a comparative bioavailability study. | | Author(s) | Rigato HM, Moreno RA, Orpinelli EZ, Borges BC, Sverdloff CE, Pedrazzoli Jr J, Borges NC | | Institution | 1Department of Medical Clinic, 2Department of Pharmacology, State University of Campinas, 3Synchrophar Assessoria e Desenvolvimento de Projetos Clínicos, Campinas, SP, 4College of Medicine, Pontificia Universidade Católica, Sorocaba, SP, 5Integrated Unit of Pharmacology and Gastroenterology, Sao Francisco University Medical School, Bragança Paulista/SP, Brazil. | | Source | Int J Clin Pharmacol Ther 2009 Feb; Volume 47(February):132-140. | | Abstract | A rapid, sensitive and specific method to quantify diclofenac in human plasma using indomethacin as the internal standard (IS) is described. Samples were extracted using protein precipitation protocol and analyzed by high performance liquid chromatography coupled to ultraviolet detection at 276 nm. Chromatography was performed isocratically with a run time of 8.0 min and the retention time observed for diclofenac and IS was 6.0 and 7.0 min, respectively. The calibration curve was linear over the range 50 - 4,000 ng/ml (r2 > 0.9995). The mean recovery of diclofenac ranged from 88.76 to 99.14% and the limit of quantification was 50 ng/ml. Intrabatch precision and accuracy (%CV) of the method ranged from 0.86 to 7.60%, and 99.34 to 103.8%, respectively. Interbatch precision (%CV) and accuracy ranged from 0.26 to 11.4%, and 92.00 to 105.34%, respectively. This HPLC method was used to determine the relative pharmacokinetics of two diclofenac-cholestyramine 140 mg capsule formulations. The study was conducted using an open, randomized and crossover design with a 1-week washout interval. A single 140 mg dose (equivalent to 70 mg of diclofenac) of each formulation was administered to 26 healthy volunteers (13 males and 13 females) and blood samples were obtained over 12-h interval. The geometric mean of diclofenac-cholestyramine/Flotac(R) ratio was 90.53% for AUC0-12 and 100.22% for Cmax. Since the 90% CI for Cmax and AUCs ratios were all inside the 80 - 125% interval, it was concluded that the diclofenac-cholestyramine test formulation is bioequivalent to Flotac(R) regarding both the rate and the extent of absorption. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19203570 |
|
